M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 470-477

  Hoglund A U ^a   Baghdoyan, H A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; METHOCTRAMINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; OTENZEPAD; PIRENZEPINE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SPINAL CORD; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BINDING, COMPETITIVE; MALE; RATS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; SPINAL CORD;

EID: 0030958039     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. ABRAM, S. E. AND O'CONNOR, T. C.: Characteristics of the analgesic effects and drug interactions of intrathecal carbachol in rats. Anesthesiology 83: 844-849, 1995.
2. ABRAM, S. E. AND WINNE, R. P.: Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats. Anesth. Analg. 81: 501-507, 1995.
3. 3H] 4-DAMP to muscarinic cholinergic sites in the rat brain: Evidence from membrane binding and autoradiographic studies. Synapse 9: 165-176, 1991.
4. 3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. Eur. J. Pharmacol. 217: 173-184, 1992.
5. BAGHDOYAN, H. A., MALLIOS, V. J., DUCKROW, R. B. AND MASH, D. C.: Localization of muscarinic receptor subtypes in brain stem areas regulating sleep. NeuroReport 5: 1631-1634, 1994.
6. BIRDSALL, N., BUCKLEY, N., DOODS, H., FUKUDA, K., GIACHETTI, A., HAMMER, R., KILBINGER. H., LAMBRECHT, G., MUTSCHLER, E., NATHANSON, N., NORTH. A. AND SCHWARZ, R.: Nomenclature for muscarinic receptor subtypes recommended by symposium. Trends Pharmacol. Sci. December: suppl. vii, 1989.
7. BOLDEN, C., CUSACK, B. AND RICHELSON, E.: Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 260: 576-260, 1991.
8. BONNER, T. L. BUCKLEY, N. J., YOUNG, A. C. AND BRANS, M. R.: Identification of a family of muscarinic acetylcholine receptor genes. Science (Wash. DC) 237: 527-532, 1987.
9. BORENSTEIN, M. T., SANTIAGO, M., VALENTINE, H. H. AND POTTER, L. T.: Autoradiographic evidence that m4 muscarinic receptors modulate nociception in the human spinal cord (Abstract). Soc. Neurosci. 22: 871, 1996.
10. BOUAZIZ, H., TONG, C. AND EISENACH, J. C.: Postoperative analgesia from intrathecal neostigmine in sheep. Anesth. Analg. 80: 1140-1144, 1995.
11. BUCCAFUSCO, J. J.: The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol. Rev. 48: 179-211, 1996.
12. CARP, H., JAYARAM, A. AND MORROW, D.: Intrathecal cholinergic agonists lessen bupivacaine spinal-block-induced hypotension in rats. Anesth. Analg. 79: 112-116, 1994.
13. CAULFIELD, M. P.: Muscarinic receptors-characterization, coupling and function. Pharmacol. Ther. 58: 319-379, 1993.
14. COLLINS, J. G.: Spinally administered neostigmine-something to celebrate. Anesthesiology 82: 327-328, 1995.
15. DETWEILER, D. J., EISENACH, J. C., TONG, C. AND JACKSON, C.: A cholinergic interaction in alpha 2 adrenoceptor-mediated antinociception in sheep. J. Pharmacol. Exp. Ther. 265: 536-542, 1993.
16. DÖRJE, F., WESS, J., LAMBRECHT, G., TACKE, R., MUTSCHLER, E. AND BRANN, M. R.: Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256: 727-733, 1990.
17. FELDMAN, D. S., TERRY, A. V. AND BUCCAFUSCO, J. J.: Spinal muscarinic cholinergic and nitric oxide systems in cardiovascular regulation. Eur. J. Pharmacol. 313: 211-220, 1996.
18. FLYNN, D. D. AND MASH, D. C.: Distinct kinetic binding properties of N-[3H]methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Synapse 14: 283-296, 1993.
19. FREY, K. A. AND HOWLAND, M. M.: Quantitative autoradiography of muscarinic cholinergic receptor binding in the rat brain: Distinction of receptor subtypes in antagonist competition assays. J. Pharmacol. Exp. Ther. 263: 1391-1400, 1992.
20. GEARY, W. A., TOGA, A. W. AND WOOTEN, G. F.: Quantitative film autoradiography for tritium: Methodological considerations. Brain Res. 337: 99-108, 1985.
21. GILLBERG, P. G., D'ARGY, R. AND AQUILONIUS, S. M.: Autoradiographic distribution of [3H] lacetylcholine binding sites in the cervical spinal cord of man and some other species. Neurosci. Lett. 90: 197-202, 1988.
22. GILLBERG, P. G., NORDBERG, A. AND AQUILONIUS, S. M.: Muscarinic binding sites in small homogenates and in autoradiographic sections from rat and human spinal cord. Brain Res. 300: 327-333, 1984.
23. HERKENHAM, M. AND PERT, C. B.: Light microscopic localization of brain opiate receptors: A general autoradiographic method which preserves tissue quality. J. Neurosci. 2: 1129-1149, 1982.
24. HOOD, D. D., EISENACH, J. C. AND TUTTLE, R.: Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology 82: 331-343, 1995.
25. IWAMOTO, E. T. AND MARION, L.: Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther. 266: 329-338, 1993.
26. JAKUBIK, J., BACAKOVA, L., EL-FAKAHANY, E. E. AND TUCEK, S.: Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 274: 1077-1083, 1995.
27. KAYAALP, S. O. AND NEFF, N. H.: Regional distribution of cholinergic muscarinic receptors in spinal cord. Brain Res. 196: 429-436, 1980.
28. KENDIG, J. J.: Spinal cord as a site of anesthetic action. Anesthesiology 79: 1161-1162, 1993.
29. KUBO, T., FUKUDA, K., MIKAMI, A., MAEDA, A., TAKAHASHI, H., MISHINA, M., HAGA, T., HAGA, K., ICHIYAMA, A., KANAGAWA, K., KOJIMA, M., MATSUO, H., HIROSE, T. AND NUMA, S.: Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (Lond.) 323: 411416, 1986.
30. KUHAR, M. J. AND UNNERSTALL, J. R.: Receptor autoradiography. In Methods in Neurotransmitter Receptor Analysis, ed. by H. I. Yamamura, S. J. Enna and M. J. Kuhar, pp. 177-218, Raven Press, New York, 1990.
31. LAURETTI, G. R., REIS, M. P., PRADO, W. A. AND KLAMT, J. G.: Dose-response study of intrathecal morphine versus intrathecal neostigmine. their combination, or placebo for postoperative analgesia in patients undergoing anterior and posterior vaginoplasty. Anesth. Analg. 82: 1182-1187, 1996.
32. LEVEY, A. I., EDMUNDS, S. M., HERSCH, S. M., WILEY. R. G. AND HEILMAN, C. J.: Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of rat. J. Comp. Neurol. 351: 339-356, 1995.
33. LOTHE, A., Li, P., TONG, C., YOON, Y., BOUAZIZ, H., DETWEILER, D. J. AND EISENACH, J. C.: Spinal cholinergic alpha-2 adrenergic interactions in analgesia and hemodynamic control: Role of muscarinic receptor subtypes and nitric oxide. J. Pharmacol. Exp. Ther. 270: 1301-1306, 1994.
34. MALLIOS, V. J., LYDIC, R. AND BAGHDOYAN, H. A.: Muscarinic receptor subtypes are differentially distributed across brain stem respiratory nuclei. Am. J. Physiol. 268: L941-949, 1995.
35. MUNSON, P. J. AND RODBARD, D.: LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
36. NAGUIB, M. AND YAKSH, T. L.: Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with μ and α2 receptor systems. Anesthesiology 80: 1338-1348, 1994.
37. QUIRION, R., AUBERT, I., ARAUJO, D. M., HERSI, A. AND GAUDREAU, P.: Autoradiographic distribution of putative muscarinic receptor subtypes in mammalian brain. Prog. Brain. Res. 98: 85-93, 1993.
38. REXED, B.: The cytoarchitectonic organization of the spinal cord of the cat. J. Comp. Neurol. 96: 415-496, 1952.
39. SCATTON, B., DUBOIS, A., JAVOY-AGID, F. AND CAMUS, A.: Autoradiographic localization of muscarinic cholinergic receptors at various segmental levels of the human spinal cord. Neurosci. Lett. 49: 239-245, 1984.
40. SEYBOLD, V. S. AND ELDE, R. P.: Receptor autoradiography in thoracic spinal cord: Correlation of the neurotransmitter binding sites with sympathoadrenal neurons. J. Neurosci. 4: 2533-2542, 1984.
41. SMITH, M. D., YANG, X., NHA, J.-Y. AND BUCCAFUSCO, J. J.: Antinociceptive effect of spinal cholinergic stimulation: Interaction with substance P. Life Sci. 45: 1255-1261, 1989.
42. VILARO, M. T., MENGOD, G. AND PALACIOS, J. M.: Advances and limitations of the molecular neuroanatomy of cholinergic receptors: The example of multiple muscarinic receptors. Prog. Brain Res. 98: 95-101, 1993.
43. VILLIGER, J. W. AND FAULL, R. L.: Muscarinic cholinergic receptors in the human spinal cord: Differential localization of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding sites. Brain Res. 345: 196-199, 1985.
44. WAELBROECK, M., GILLARD, M., ROBBERECHT, P. AND CHRISTOPHE, J.: Kinetic-studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: Evidence for the existence of three classes of binding sites. Mol. Pharmacol. 30: 305-314, 1986.
45. WAELBROECK, M., TASTENOY, M., CAMUS, J. AND CHRISTOPHE, J.: Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol. Pharmacol. 38: 267-273, 1990.
46. WAMSLEY, J. K., GEHLERT, D. R., ROESKE, W. R. AND YAMAMURA, H. I.: Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine. Life Sci. 34: 1395-1402, 1984.
47. WATSON, M., YAMAMURA, H. I. AND ROESKE, W. R.: A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct Ml and M2 muscarinic receptor subtypes. Life Sci. 32: 3001-3011, 1983.
48. WEI, J., WALTON, E. A., MILICI, A. AND BUCCAFUSCO, J. J.: m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 63: 815-821, 1994.
49. WILLIAMS, J. S., TONG, C. AND EISENACH, J. C.: Neostigmine counteracts spinal clonidine-induced hypotension in sheep. Anesthesiology 78: 301-307, 1993.
50. YAKSH, T. L., GRAFE, M. R., MALKMUS, S., RATHBUN, M. L. AND EISENACH, J. C.: Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 82: 412-427, 1995.
51. YAMAMURA, H. I., WAMSLEY, J. K., DESHMUKH, P. AND ROESKE, W. R.: Differential light microscopic autoradiographic localization of muscarinic cholinergic receptors in the brainstem and spinal cord of the rat using [3H]pirenzepine. Eur. J. Pharmacol. 91: 147-149, 1983.
52. ZHUO, M. AND GEBHART, G. F.: Tonic cholinergic inhibition of spinal mechanical transmission. Pain 46: 211-222, 1991.
53. ZUBIETA, J. K. AND FREY, K. A.: Autoradiographic mapping of M3 muscarinic receptors in the rat brain. J. Pharmacol. Exp. Ther. 264: 415-422, 1993.